Mitra Ashim K, Agrahari Vibhuti, Mandal Abhirup, Cholkar Kishore, Natarajan Chandramouli, Shah Sujay, Joseph Mary, Trinh Hoang M, Vaishya Ravi, Yang Xiaoyan, Hao Yi, Khurana Varun, Pal Dhananjay
Division of Pharmaceutical Sciences, School of Pharmacy, University of Missouri-Kansas City, 2464 Charlotte Street, Kansas City, MO 64108, USA.
Division of Pharmaceutical Sciences, School of Pharmacy, University of Missouri-Kansas City, 2464 Charlotte Street, Kansas City, MO 64108, USA.
J Control Release. 2015 Dec 10;219:248-268. doi: 10.1016/j.jconrel.2015.09.067. Epub 2015 Oct 9.
Currently, a majority of cancer treatment strategies are based on the removal of tumor mass mainly by surgery. Chemical and physical treatments such as chemo- and radiotherapies have also made a major contribution in inhibiting rapid growth of malignant cells. Furthermore, these approaches are often combined to enhance therapeutic indices. It is widely known that surgery, chemo- and radiotherapy also inhibit normal cells growth. In addition, these treatment modalities are associated with severe side effects and high toxicity which in turn lead to low quality of life. This review encompasses novel strategies for more effective chemotherapeutic delivery aiming to generate better prognosis. Currently, cancer treatment is a highly dynamic field and significant advances are being made in the development of novel cancer treatment strategies. In contrast to conventional cancer therapeutics, novel approaches such as ligand or receptor based targeting, triggered release, intracellular drug targeting, gene delivery, cancer stem cell therapy, magnetic drug targeting and ultrasound-mediated drug delivery, have added new modalities for cancer treatment. These approaches have led to selective detection of malignant cells leading to their eradication with minimal side effects. Lowering multi-drug resistance and involving influx transportation in targeted drug delivery to cancer cells can also contribute significantly in the therapeutic interventions in cancer.
目前,大多数癌症治疗策略主要基于通过手术切除肿瘤块。化学和物理治疗方法,如化疗和放疗,在抑制恶性细胞的快速生长方面也做出了重大贡献。此外,这些方法常常联合使用以提高治疗指数。众所周知,手术、化疗和放疗也会抑制正常细胞的生长。此外,这些治疗方式伴有严重的副作用和高毒性,进而导致生活质量低下。本综述涵盖了旨在产生更好预后的更有效化疗给药的新策略。目前,癌症治疗是一个高度动态的领域,新型癌症治疗策略的开发正在取得重大进展。与传统癌症治疗方法不同,基于配体或受体的靶向、触发释放、细胞内药物靶向、基因递送、癌症干细胞治疗、磁性药物靶向和超声介导的药物递送等新方法为癌症治疗增添了新的模式。这些方法能够选择性地检测恶性细胞,从而在副作用最小的情况下将其根除。降低多药耐药性并在靶向癌细胞的药物递送中涉及流入转运,也可在癌症治疗干预中发挥重要作用。